Bio-Techne Corp
(FRA:TE1)
€
67
0 (0%)
Market Cap: 10.70 Bil
Enterprise Value: 10.94 Bil
PE Ratio: 71.88
PB Ratio: 5.72
GF Score: 95/100 Bio-Techne Corp at Stifel Virtual Healthcare Conference Transcript
Nov 16, 2020 / 06:20PM GMT
Release Date Price:
€62.5
(-1.57%)
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Okay. Welcome back to the Life Sciences track of the Stifel Healthcare Conference. Our next company is Bio-Techne. We're happy to have Chuck Kummeth and Jim Hippel here with us. Guys, thanks a bunch for joining us today.
Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director
Good to be here.
Questions & Answers
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Good old-fashioned fireside chat. I figure we could just sort of take 30 minutes and walk through the business, some of the things that you're seeing, some of the ways that you're thinking about the outlook.
And maybe just to jump right into it, Chuck, you've always kind of been a guy that's had a good finger on the pulse of his customer base. There's obviously a lot going on in terms of what the impact of COVID is and how labs of different types are
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot